Cargando…
Nuclear β-arrestin1 is a critical cofactor of hypoxia-inducible factor-1α signaling in endothelin-1-induced ovarian tumor progression
Hypoxia-inducible factor-1α (HIF-1α) mediates the response to hypoxia or other stimuli, such as growth factors, including endothelin-1 (ET-1), to promote malignant progression in numerous tumors. The importance of cofactors that regulate HIF-1α signalling within tumor is not well understood. Here we...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951250/ https://www.ncbi.nlm.nih.gov/pubmed/26909598 http://dx.doi.org/10.18632/oncotarget.7461 |
_version_ | 1782443668059193344 |
---|---|
author | Cianfrocca, Roberta Tocci, Piera Rosanò, Laura Caprara, Valentina Sestito, Rosanna Di Castro, Valeriana Bagnato, Anna |
author_facet | Cianfrocca, Roberta Tocci, Piera Rosanò, Laura Caprara, Valentina Sestito, Rosanna Di Castro, Valeriana Bagnato, Anna |
author_sort | Cianfrocca, Roberta |
collection | PubMed |
description | Hypoxia-inducible factor-1α (HIF-1α) mediates the response to hypoxia or other stimuli, such as growth factors, including endothelin-1 (ET-1), to promote malignant progression in numerous tumors. The importance of cofactors that regulate HIF-1α signalling within tumor is not well understood. Here we elucidate that ET-1/ET(A) receptor (ET(A)R)-induced pathway physically and functionally couples the scaffold protein β-arrestin1 (β-arr1) to HIF-1α signalling. In epithelial ovarian cancer (EOC) cells, ET-1/ET(A)R axis induced vascular-endothelial growth factor (VEGF) expression through HIF-1α nuclear accumulation. In these cells, activation of ET(A)R by ET-1, by mimicking hypoxia, promoted the nuclear interaction between β-arr1 and HIF-1α and the recruitment of p300 acetyltransferase to hypoxia response elements on the target gene promoters, resulting in enhanced histone acetylation, and HIF-1α target gene transcription. Indeed, β-arr1-HIF-1α interaction regulated the enhanced expression and release of downstream targets, such as ET-1 and VEGF, required for tumor cell invasion and pro-angiogenic effects in endothelial cells. These effects were abrogated by β-arr1 or HIF-1α silencing or by pharmacological treatment with the dual ET-1 receptor antagonist macitentan. Interestingly, ET(A)R/β-arr1 promoted the self-amplifying HIF-1α-mediated transcription of ET-1 that sustained a regulatory circuit involved in invasive and angiogenic behaviors. In a murine orthotopic model of metastatic human EOC, treatment with macitentan, or silencing of β-arr1, inhibits intravasation and metastasis formation. Collectively, these findings reveal the interplay of β-arr1 with HIF-1α in the complexity of ET-1/ET(A)R signalling, mediating epigenetic modifications directly involved in the metastatic process, and suggest that targeting ET-1-dependent β-arr1/HIF-1α pathway by using macitentan may impair EOC progression. |
format | Online Article Text |
id | pubmed-4951250 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-49512502016-07-21 Nuclear β-arrestin1 is a critical cofactor of hypoxia-inducible factor-1α signaling in endothelin-1-induced ovarian tumor progression Cianfrocca, Roberta Tocci, Piera Rosanò, Laura Caprara, Valentina Sestito, Rosanna Di Castro, Valeriana Bagnato, Anna Oncotarget Research Paper Hypoxia-inducible factor-1α (HIF-1α) mediates the response to hypoxia or other stimuli, such as growth factors, including endothelin-1 (ET-1), to promote malignant progression in numerous tumors. The importance of cofactors that regulate HIF-1α signalling within tumor is not well understood. Here we elucidate that ET-1/ET(A) receptor (ET(A)R)-induced pathway physically and functionally couples the scaffold protein β-arrestin1 (β-arr1) to HIF-1α signalling. In epithelial ovarian cancer (EOC) cells, ET-1/ET(A)R axis induced vascular-endothelial growth factor (VEGF) expression through HIF-1α nuclear accumulation. In these cells, activation of ET(A)R by ET-1, by mimicking hypoxia, promoted the nuclear interaction between β-arr1 and HIF-1α and the recruitment of p300 acetyltransferase to hypoxia response elements on the target gene promoters, resulting in enhanced histone acetylation, and HIF-1α target gene transcription. Indeed, β-arr1-HIF-1α interaction regulated the enhanced expression and release of downstream targets, such as ET-1 and VEGF, required for tumor cell invasion and pro-angiogenic effects in endothelial cells. These effects were abrogated by β-arr1 or HIF-1α silencing or by pharmacological treatment with the dual ET-1 receptor antagonist macitentan. Interestingly, ET(A)R/β-arr1 promoted the self-amplifying HIF-1α-mediated transcription of ET-1 that sustained a regulatory circuit involved in invasive and angiogenic behaviors. In a murine orthotopic model of metastatic human EOC, treatment with macitentan, or silencing of β-arr1, inhibits intravasation and metastasis formation. Collectively, these findings reveal the interplay of β-arr1 with HIF-1α in the complexity of ET-1/ET(A)R signalling, mediating epigenetic modifications directly involved in the metastatic process, and suggest that targeting ET-1-dependent β-arr1/HIF-1α pathway by using macitentan may impair EOC progression. Impact Journals LLC 2016-02-17 /pmc/articles/PMC4951250/ /pubmed/26909598 http://dx.doi.org/10.18632/oncotarget.7461 Text en Copyright: © 2016 Cianfrocca et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Cianfrocca, Roberta Tocci, Piera Rosanò, Laura Caprara, Valentina Sestito, Rosanna Di Castro, Valeriana Bagnato, Anna Nuclear β-arrestin1 is a critical cofactor of hypoxia-inducible factor-1α signaling in endothelin-1-induced ovarian tumor progression |
title | Nuclear β-arrestin1 is a critical cofactor of hypoxia-inducible factor-1α signaling in endothelin-1-induced ovarian tumor progression |
title_full | Nuclear β-arrestin1 is a critical cofactor of hypoxia-inducible factor-1α signaling in endothelin-1-induced ovarian tumor progression |
title_fullStr | Nuclear β-arrestin1 is a critical cofactor of hypoxia-inducible factor-1α signaling in endothelin-1-induced ovarian tumor progression |
title_full_unstemmed | Nuclear β-arrestin1 is a critical cofactor of hypoxia-inducible factor-1α signaling in endothelin-1-induced ovarian tumor progression |
title_short | Nuclear β-arrestin1 is a critical cofactor of hypoxia-inducible factor-1α signaling in endothelin-1-induced ovarian tumor progression |
title_sort | nuclear β-arrestin1 is a critical cofactor of hypoxia-inducible factor-1α signaling in endothelin-1-induced ovarian tumor progression |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951250/ https://www.ncbi.nlm.nih.gov/pubmed/26909598 http://dx.doi.org/10.18632/oncotarget.7461 |
work_keys_str_mv | AT cianfroccaroberta nuclearbarrestin1isacriticalcofactorofhypoxiainduciblefactor1asignalinginendothelin1inducedovariantumorprogression AT toccipiera nuclearbarrestin1isacriticalcofactorofhypoxiainduciblefactor1asignalinginendothelin1inducedovariantumorprogression AT rosanolaura nuclearbarrestin1isacriticalcofactorofhypoxiainduciblefactor1asignalinginendothelin1inducedovariantumorprogression AT capraravalentina nuclearbarrestin1isacriticalcofactorofhypoxiainduciblefactor1asignalinginendothelin1inducedovariantumorprogression AT sestitorosanna nuclearbarrestin1isacriticalcofactorofhypoxiainduciblefactor1asignalinginendothelin1inducedovariantumorprogression AT dicastrovaleriana nuclearbarrestin1isacriticalcofactorofhypoxiainduciblefactor1asignalinginendothelin1inducedovariantumorprogression AT bagnatoanna nuclearbarrestin1isacriticalcofactorofhypoxiainduciblefactor1asignalinginendothelin1inducedovariantumorprogression |